Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway
Theranostics · 2023
DOI: 10.7150/thno.85361 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Tianbao Ye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China. Hauptthemen laut MEDLINE: Myocardial Infarction, Heart Failure. Die Arbeit wurde bisher 42-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China.
- Youth Science and Technology Innovation Studio of Shanghai Jiao Tong University School of Medicine, Shanghai 200233, China.
- School of Medicine, Tongji University, Shanghai 200092, China.
Zitieren
APA
Ye, T., Yan, Z., Chen, C., Wang, D., Wang, A., Li, T., Yang, B., Ding, X., & Shen, C. (2023). Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway. Theranostics. https://doi.org/10.7150/thno.85361
Vancouver
Ye T, Yan Z, Chen C, Wang D, Wang A, Li T, et al. Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway. Theranostics. 2023. doi:10.7150/thno.85361
BibTeX
@article{Ye2023,
author = {Ye, Tianbao and Yan, Zhiwen and Chen, Cheng and Wang, Di and Wang, Aiting and Li, Taixi and Yang, Boshen and Ding, Xianting and Shen, Chengxing},
title = {Lactoferrin attenuates cardiac fibrosis and cardiac remodeling after myocardial infarction via inhibiting mTORC1/S6K signaling pathway},
journal = {Theranostics},
year = {2023},
doi = {10.7150/thno.85361}
}
EUVIMED